Press Release 2025 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Dr. Alphons Philips Joins Sabinsa as Director-Scientific Affairs

Sabinsa to Feature Portfolio of Well-Researched, Category Leading Ingredients at SupplySide Connect New Jersey

Study Reveals Beetroot Extract Improves Carotid Artery Stiffness in Postmenopausal Women

Sabinsa Founder Dr. Muhammed Majeed Posthumously Honored by AHPA with Visionary Award for His Enduring Legacy

Sabinsa to Feature Portfolio of Science-supported Ingredients at Expo West, Showcase Ayurvedic Brand Nature’s Formulary Products

Sabinsa Acquires Established Ayurvedic Brand Nature’s Formulary, Names PK Davé CEO of Sabinsa’s Consumer Goods Division

Certificates

Global Offices

Get in Touch

Disclaimer